RETROSPECTIVE EXAMINATION OF CLINICAL PHARMACOLOGY REVIEWS FROM FDA ON ONCOLOGY BIOLOGICS FOR POTENTIAL BENEFIT OF THERAPEUTIC DRUG MONITORING.

被引：0
|
作者：
Fleisher, B. A. [1 ]
Aitoudhia, S. [1 ]
机构：
[1] Univ Florida, Orlando, FL USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI-070
引用
收藏
页码：S32 / S32
页数：1
相关论文
共 7 条
  • [1] A retrospective examination of the US Food and Drug Administration's clinical pharmacology reviews of oncology biologics for potential use of therapeutic drug monitoring
    Fleisher, Brett
    Ait-Oudhia, Sihem
    ONCOTARGETS AND THERAPY, 2018, 11 : 113 - 121
  • [2] Caveats of Retrospective Data Analyses from Therapeutic Drug Monitoring Clinical Pathways
    Kamperidis, N.
    Stasinos, I.
    Arebi, N.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 (06): : 876 - 877
  • [3] LEARNINGS FROM FDA CLINICAL PHARMACOLOGY (CP) REVIEWS OF ONCOLOGY (ONC) NEW MOLECULAR ENTITIES (NMES) APPROVED FROM 2011 TO 2015.
    Faucette, S.
    Trivedi, A.
    Gupta, N.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S93 - S93
  • [4] TRANSLATIONAL VALUE OF PRECLINICAL STUDIES FOR CLINICAL BENEFIT IN ONCOLOGY: RETROSPECTIVE INVESTIGATION OF US FOOD AND DRUG ADMINSTRATION (FDA) - APPROVED SMALL--MOLECULE DRUGS.
    Liu, W.
    Morcos, P.
    Yu, L.
    Brennan, B.
    Mercier, F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S53 - S54
  • [5] CHALLENGES IN COMPARING TREATMENT OUTCOME FROM A PROSPECTIVE WITH THAT OF A RETROSPECTIVE STUDY - ASSESSING THE MERIT OF GENTAMICIN THERAPEUTIC DRUG-MONITORING IN PEDIATRIC ONCOLOGY
    HO, KKL
    THIESSEN, JJ
    BRYSON, SM
    GREENBERG, ML
    EINARSON, TR
    LESON, CL
    THERAPEUTIC DRUG MONITORING, 1994, 16 (03) : 238 - 247
  • [6] Evaluation of Therapeutic Drug Monitoring in the Clinical Management of Patients with Rheumatic Diseases: Data from a Retrospective Single-Center Cohort Study
    Pedersen, Lise
    Szecsi, Pal Bela
    Johansen, Per Birger
    Bjerrum, Poul Jannik
    BIOLOGICS-TARGETS & THERAPY, 2020, 14 : 115 - 125
  • [7] Therapeutic drug monitoring -guided continuous infusion of Piperacillin/Tazobactam significantly improves pharmacokinetic target-attainment in critically ill patients: a retrospective analysis from four years of clinical experience
    Richter, D. C.
    Frey, O.
    Rohr, A.
    Roberts, J. A.
    Koeberer, A.
    Fuchs, Th
    Brenner, T.
    Lichtenstein, C.
    Weigand, M. A.
    Brinkmann, A.
    INFECTION, 2019, 47 : S46 - S47
1